Entera Bio Ltd. (ENTX)
2.84
-0.17
(-5.65%)
USD |
NASDAQ |
Sep 09, 16:00
2.86
+0.02
(+0.70%)
After-Hours: 19:02
Entera Bio Market Cap : 139.98M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 148.36M |
| September 04, 2026 | 147.87M |
| September 03, 2026 | 145.41M |
| September 02, 2026 | 143.93M |
| September 01, 2026 | 142.94M |
| August 31, 2026 | 145.41M |
| August 28, 2026 | 149.35M |
| August 27, 2026 | 151.81M |
| August 26, 2026 | 157.24M |
| August 25, 2026 | 171.04M |
| August 24, 2026 | 168.57M |
| August 21, 2026 | 159.21M |
| August 20, 2026 | 158.71M |
| August 19, 2026 | 153.29M |
| August 18, 2026 | 142.45M |
| August 17, 2026 | 142.94M |
| August 14, 2026 | 142.45M |
| August 13, 2026 | 141.46M |
| August 12, 2026 | 138.01M |
| August 11, 2026 | 147.87M |
| August 10, 2026 | 149.84M |
| August 07, 2026 | 141.46M |
| August 06, 2026 | 139.00M |
| August 05, 2026 | 138.51M |
| August 04, 2026 | 133.81M |
| Date | Value |
|---|---|
| August 03, 2026 | 138.00M |
| July 31, 2026 | 139.40M |
| July 30, 2026 | 137.54M |
| July 29, 2026 | 139.87M |
| July 28, 2026 | 151.99M |
| July 27, 2026 | 182.76M |
| July 24, 2026 | 95.58M |
| July 23, 2026 | 99.31M |
| July 22, 2026 | 94.64M |
| July 21, 2026 | 91.38M |
| July 20, 2026 | 92.78M |
| July 17, 2026 | 92.31M |
| July 16, 2026 | 93.24M |
| July 15, 2026 | 82.99M |
| July 14, 2026 | 75.53M |
| July 13, 2026 | 76.46M |
| July 10, 2026 | 77.16M |
| July 09, 2026 | 79.26M |
| July 08, 2026 | 78.79M |
| July 07, 2026 | 77.39M |
| July 06, 2026 | 79.72M |
| July 02, 2026 | 77.39M |
| July 01, 2026 | 78.79M |
| June 30, 2026 | 82.52M |
| June 29, 2026 | 76.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioLineRx Ltd. | 11.10M |
| XTL Biopharmaceuticals Ltd. | 5.961M |
| Kamada Ltd. | 473.67M |
| Can-Fite BioPharma Ltd. | 2.896M |
| Galmed Pharmaceuticals Ltd. | 4.586M |
Market Cap Related Metrics
| PEG Ratio | -0.2188 |
| Price to Book Value | 19.27 |
| Price | 2.84 |
| Earnings Yield | -12.38% |
| PEGY Ratio | -0.2188 |